Siolta Therapeutics has a total of 34 patents globally, out of which 4 have been granted. Of these 34 patents, more than 62% patents are active. United States of America is where Siolta Therapeutics has filed the maximum number of patents, followed by Europe (EPO) and Japan. Parallelly, USA seems to be the main focused R&D centre and also is the origin country of Siolta Therapeutics.
Siolta Therapeutics founded in 2016, Siolta Therapeutics develops human microbiome-based therapeutics aimed at preventing and treating inflammatory diseases. By leveraging its expertise in the gut microbiome and its role in immune tolerance, the company creates targeted microbial treatments and companion diagnostics. Siolta enables medical researchers to use microbiome insights to design next-generation therapies for inflammatory conditions.
Do read about some of the most popular patents of Siolta Therapeutics which have been covered by us in this article and also you can find Siolta Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Siolta Therapeutics patent portfolio.
How many patents does Siolta Therapeutics have?
Siolta Therapeutics has a total of 34 patents globally. These patents belong to 6 unique patent families. Out of 34 patents, 21 patents are active.
How Many Patents did Siolta Therapeutics File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Siolta Therapeutics Applications Filed | Siolta Therapeutics Patents Granted |
| 2025 | 1 | 1 |
| 2024 | 3 | – |
| 2023 | 7 | 1 |
| 2022 | 7 | 2 |
| 2021 | 3 | – |
| 2020 | 9 | – |
| 2019 | 4 | – |
How many Siolta Therapeutics patents are Alive/Dead?
Worldwide Patents
How Many Patents did Siolta Therapeutics File in Different Countries?
Countries in which Siolta Therapeutics Filed Patents
| Country | Patents |
| United States of America | 10 |
| Europe (EPO) | 5 |
| Japan | 4 |
| China | 3 |
| Hong Kong (S.A.R.) | 3 |
| Korea (South) | 1 |
| Canada | 1 |
| Australia | 1 |
Where are Research Centres of Siolta Therapeutics Patents Located?
The Research Centre for all the Siolta Therapeutics patents is the United States of America.
Siolta Therapeutics Best Patent
WO2019199895A1 is the most popular patent in the Siolta Therapeutics portfolio. It has received 12 citations so far from companies like Biomica and Enterobiome.
What Percentage of Siolta Therapeutics US Patent Applications were Granted?
Siolta Therapeutics (Excluding its subsidiaries) has filed 8 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 3 have been granted leading to a grant rate of 75.0%.
Below are the key stats of Siolta Therapeutics patent prosecution at the USPTO.
Which Law Firms are managing US Patents for Siolta Therapeutics?
| Law Firm | Total Applications | Success Rate |
| Wilson Sonsini Goodrich & Rosati | 8 | 75.00% |
List of Siolta Therapeutics Patents
| Siolta Therapeutics Patents | Title |
| JP7624449B2 | Therapeutic Pharmaceutical Compositions |
| US20250213629A1 | Therapeutic Pharmaceutical Compositions |
| US20250205292A1 | Pharmaceutical Compositions And Uses Thereof |
| EP4536256A2 | Pharmaceutical Compositions And Uses Thereof |
| EP4319776A4 | Pharmaceutical Compositions For Treating Diseases |
| JP2025063222A5 | Therapeutic Pharmaceutical Compositions |
| JP2025523392A | Pharmaceutical Composition And Its Use |
| JP2024514811A5 | Pharmaceutical Compositions For Treating Diseases |
| US20240183861A1 | Pharmaceutical Compositions And Uses Thereof |
| US20240091278A1 | Pharmaceutical Compositions For Treating Diseases |
| US20240173368A1 | Therapeutic Pharmaceutical Compositions |
| CN117460520A | Pharmaceutical Composition For Treating Diseases |
| WO2023240160A3 | Pharmaceutical Compositions And Uses Thereof |
| HK40106269A | Pharmaceutical Compositions For Treating Diseases |
| US11806373B2 | Therapeutic Pharmaceutical Compositions |
| WO2022251309A3 | Pharmaceutical Compositions And Uses Thereof |
| WO2022216852A9 | Pharmaceutical Compositions For Treating Diseases |
| HK40081359A | Therapeutic Pharmaceutical Compositions |
| US11406675B2 | Therapeutic Pharmaceutical Compositions |
| US11369644B2 | Microbial Consortia |
| US20220378850A1 | Microbial Consortia |
| EP4041264A1 | Therapeutic Pharmaceutical Compositions |
| EP3927375A4 | Compositions For Disease Treatment |
| CN114786690A | Therapeutic Pharmaceutical Composition |
| KR1020220108765A | Therapeutic Pharmaceutical Composition |
| US20210380651A1 | Compositions For Disease Treatment |
| EP3773645A4 | Microbial Consortia |
| CN113038957A | Microbial Consortia |
| WO2021071864A1 | Therapeutic Pharmaceutical Compositions |
| HK40047120A | Microbial Consortia |
| CA3153884A1 | Therapeutic Pharmaceutical Compositions |
| WO2020172473A1 | Compositions For Disease Treatment |
| AU2019253714A1 | Microbial Consortia |
| WO2019199895A1 | Microbial Consortia |
What are Siolta Therapeutics key innovation segments?
What Technologies are Covered by Siolta Therapeutics?
The chart below distributes patents filed by Siolta Therapeutics in different countries on the basis of the technology protected in patents. It also represents the markets where Siolta Therapeutics thinks it’s important to protect particular technological inventions.
R&D Focus: How has Siolta Therapeutics search focus changed over the years?
EXCLUSIVE INSIGHTS COMING SOON!
Interested in knowing about the areas of innovation that are being protected by Siolta Therapeutics?
